These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 22107849

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays.
    Lorbetskie B, Wang J, Gravel C, Allen C, Walsh M, Rinfret A, Li X, Girard M.
    Vaccine; 2011 Apr 18; 29(18):3377-89. PubMed ID: 21397719
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion.
    Bodle J, Verity EE, Ong C, Vandenberg K, Shaw R, Barr IG, Rockman S.
    Influenza Other Respir Viruses; 2013 Mar 18; 7(2):191-200. PubMed ID: 22583601
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of the proficiency of single radial immunodiffusion assays for quality control of influenza vaccines in Korea.
    Choi Y, Lee S, Kwon SY, Lee Y, Park YK, Ban SJ.
    Biologicals; 2017 Nov 18; 50():137-140. PubMed ID: 29111376
    [Abstract] [Full Text] [Related]

  • 16. Critical review of current and emerging quantification methods for the development of influenza vaccine candidates.
    Manceur AP, Kamen AA.
    Vaccine; 2015 Nov 04; 33(44):5913-9. PubMed ID: 26271833
    [Abstract] [Full Text] [Related]

  • 17. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings.
    Wen Y, Palladino G, Xie Y, Ferrari A, Ma X, Han L, Dormitzer PR, Settembre EC.
    Vaccine; 2016 Jun 17; 34(29):3388-95. PubMed ID: 27154389
    [Abstract] [Full Text] [Related]

  • 18. Application of recombinant hemagglutinin proteins as alternative antigen standards for pandemic influenza vaccines.
    Choi Y, Kwon SY, Oh HJ, Shim S, Chang S, Chung HJ, Kim DK, Park Y, Lee Y.
    Biotechnol Lett; 2017 Sep 17; 39(9):1375-1380. PubMed ID: 28612264
    [Abstract] [Full Text] [Related]

  • 19. Quantitation of influenza vaccine hemagglutinin by immunoelectrophoresis.
    Mayner RE, Blackburn RJ, Barry DW.
    Dev Biol Stand; 2017 Sep 17; 39():169-78. PubMed ID: 414948
    [Abstract] [Full Text] [Related]

  • 20. Conformationally selective biophysical assay for influenza vaccine potency determination.
    Wen Y, Han L, Palladino G, Ferrari A, Xie Y, Carfi A, Dormitzer PR, Settembre EC.
    Vaccine; 2015 Oct 05; 33(41):5342-5349. PubMed ID: 26348403
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.